Bushveld Energy Update

Bushveld Minerals Limited
20 November 2023
 

Market Abuse Regulation ("MAR") Disclosure

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR. 

 

20 November 2023

Bushveld Minerals Limited

("Bushveld Minerals", "Bushveld" or the "Company")

Bushveld Energy update - Sale process initiated for CellCube

 

Bushveld Minerals Limited (AIM: BMN), the integrated primary vanadium producer, is pleased to provide an update on the company's energy operations and assets.

 

Highlights

·      Sale process initiated for Bushveld's stake in CellCube.

·      BELCO construction and commissioning completed, first batch of electrolyte undergoing qualification for compatibility with international customers.

 

Sale of stake in CellCube

The Board of Bushveld has agreed to commence a formal sale process for its interest in CellCube, the grid scale and micro-grid energy storage battery manufacturer, headquartered in Austria (also known as Enerox). The sale is in line with the Company's plans for simplifying the business and focusing on its core assets.

 

BELCO Electrolyte Facility

Commissioning and construction of the BELCO electrolyte manufacturing plant was completed in August 2023. The initial product has been distributed to international customers for qualification and compatibility prior to issuance of orders with initial feedback expected in December 2023.

 

Update on Mustang

As a fulfilment of specific fees owed to Bushveld and in repayment of the working capital loan, Mustang Energy Plc ("Mustang") declared on November 20, 2023, the issuance of 1,880,366 new ordinary shares to Bushveld. Following this issue of ordinary shares, Bushveld now holds c.15.5% of the Mustang issued share capital.

 

Furthermore, as a result of the decision to undertake a broader sale process of Bushveld's interest in CellCube, the Company will not be signing a revised Share Exchange Agreement with Mustang as this would provide ongoing exclusivity to Mustang.

 

Craig Coltman, CEO of Bushveld Minerals Limited, commented: 

"Following an extensive review and investigation of ways to unlock value, the decision to sell the underlying stake in CellCube is an important step as we work to consolidate our assets and streamline our operations on our cash generative vanadium operating facilities.

 

We are pleased with the progress we have made with our electrolyte plant, which is undergoing compliance testing with potential international customers. I look forward to updating the market once we have received further feedback."

 

 

ENDS

 

Enquiries: info@bushveldminerals.com

Bushveld Minerals Limited


+27 (0) 11 268 6555

Craig Coltman, Chief Executive Officer



Chika Edeh, Head of Investor Relations






SP Angel Corporate Finance LLP

Nominated Adviser & Broker

+44 (0) 20 3470 0470

Richard Morrison / Charlie Bouverat

 


Grant Baker / Richard Parlons

 



 


RBC Capital Markets

Joint Broker

+44 (0) 20 7653 4000

Jamil Miah / Sahil Suleman

 



 


Tavistock

Financial PR


Gareth Tredway / Tara Vivian-Neal/ James Whitaker


+44 (0) 207 920 3150

 

 

ABOUT BUSHVELD MINERALS LIMITED

Bushveld Minerals is a vertically integrated primary vanadium producer, it is one of only three operating primary vanadium producers. In 2022, the Company produced more than 3,800 mtV, representing approximately three per cent of the global vanadium market. With a diversified vanadium product portfolio serving the needs of the steel, energy and chemical sectors.

Detailed information on the Company and progress to date can be accessed on the website www.bushveldminerals.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings